Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KOD
KOD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KOD News
Healthcare Stocks Rise, Market Reacts Positively
Apr 01 2026
Yahoo Finance
Kodiak Sciences Reports Q4 Results and Cash Position
Mar 31 2026
seekingalpha
Kodiak Sciences Reports 2025 Financial Results and Business Highlights
Mar 31 2026
PRnewswire
Kodiak Sciences Stock Surpasses Analyst Target Price
Mar 27 2026
NASDAQ.COM
KODIAK SCIENCES INC: JEFFERIES INCREASES TARGET PRICE FROM $39 TO $56
Mar 27 2026
moomoo
US Stocks Plunge Amid Soaring Oil Prices
Mar 26 2026
NASDAQ.COM
Surge in Options Volume for Kodiak and Chemours
Mar 26 2026
NASDAQ.COM
Health Care Stocks Decline Late Thursday
Mar 26 2026
Yahoo Finance
US Stocks Under Pressure Amid Soaring Oil Prices
Mar 26 2026
NASDAQ.COM
Surging Oil Prices Trigger Market Volatility
Mar 26 2026
NASDAQ.COM
KODIAK SCIENCES STOCK JUMPS 40% IN PREMARKET TRADING FOLLOWING SUCCESSFUL LATE-STAGE EYE DRUG TRIAL
Mar 26 2026
moomoo
Kodiak Sciences' Zenkuda Therapy Achieves Key Milestones in Phase 3 Trial
Mar 26 2026
seekingalpha
Kodiak Sciences Shares Surge 40% on Positive Phase 3 Results for Eye Drug Zenkuda
Mar 26 2026
stocktwits
Kodiak Sciences Reports Positive Phase 3 Results for Zenkuda in Diabetic Retinopathy
Mar 26 2026
NASDAQ.COM
Kodiak Sciences Reports Positive GLOW2 Results for Zenkuda in Diabetic Retinopathy
Mar 26 2026
PRnewswire
Zenkuda Shows Superiority in Diabetic Retinopathy Treatment
Mar 26 2026
Newsfilter
Show More News
